Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer
<p>Abstract</p> <p>Background</p> <p>Adiponectin is inversely related to BMI, positively correlates with insulin sensitivity, and has anti-atherogenic effects. In recent years, adiponectin has been well studied in the field of oncology. Adiponectin has been shown to hav...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-11-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | http://www.jeccr.com/content/30/1/107 |
| _version_ | 1818495699319259136 |
|---|---|
| author | Tsukada Tomoya Fushida Sachio Harada Shinichi Terai Shiroh Yagi Yasumichi Kinoshita Jun Oyama Katsunobu Tajima Hidehiro Fujita Hideto Ninomiya Itasu Fujimura Takashi Ohta Tetsuo |
| author_facet | Tsukada Tomoya Fushida Sachio Harada Shinichi Terai Shiroh Yagi Yasumichi Kinoshita Jun Oyama Katsunobu Tajima Hidehiro Fujita Hideto Ninomiya Itasu Fujimura Takashi Ohta Tetsuo |
| author_sort | Tsukada Tomoya |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Adiponectin is inversely related to BMI, positively correlates with insulin sensitivity, and has anti-atherogenic effects. In recent years, adiponectin has been well studied in the field of oncology. Adiponectin has been shown to have antiproliferative effects on gastric cancer, and adiponectin expression is inversely correlated with clinical staging of the disease. However, no studies have reported the correlation between serum adiponectin and receptor expression with disease progression.</p> <p>Methods</p> <p>In this study, we evaluated expression levels of 2 adiponectin receptors--AdipoR1 and AdipoR2--and attempted to correlate their expression with prognosis in gastric cancer patients. AdipoR1 and AdipoR2 expression in gastric cancer cell lines (MKN45, TMK-1, NUGC3, and NUGC4) was evaluated by western blotting analysis, and the antiproliferative potential of adiponectin was examined in vitro. Serum adiponectin levels were evaluated in 100 gastric cancer patients, and the expression of AdipoR1 and AdipoR2 was assessed by immunohistochemical staining.</p> <p>Results</p> <p>MKN45 and NUGC3 expressed higher levels of AdipoR1 compared to NUGC4, even though there was no significance in AdipoR2 expression. The antiproliferative effect of adiponectin was confirmed in MKN45 and NUGC3 at 10 μg/ml. No significant associations were observed between serum adiponectin levels and clinicopathological characteristics, but lymphatic metastasis and peritoneal dissemination were significantly higher in the negative AdipoR1 immunostaining group (24/32, <it>p </it>= 0.013 and 9/32, <it>p </it>= 0.042, respectively) compared to the positive AdipoR1 group (lymphatic metastasis, 33/68; peritoneal dissemination, 8/68). On the other hand, AdipoR2 expression was only associated with histopathological type (<it>p </it>= 0.001). In survival analysis, the AdipoR1 positive staining group had significantly longer survival rates than the negative staining group (<it>p </it>= 0.01). However, multivariate analysis indicated that AdipoR1 was not an independent prognostic factor on patient's survival on gastric cancer.</p> <p>Conclusions</p> <p>In gastric cancer, adiponectin has the possibility to be involved in cell growth suppression via AdipoR1. The presence of AdipoR1 could be a novel anticancer therapeutic target in gastric cancer.</p> |
| first_indexed | 2024-12-10T18:24:13Z |
| format | Article |
| id | doaj.art-de4ae93cd7644865a4360165868702c5 |
| institution | Directory Open Access Journal |
| issn | 1756-9966 |
| language | English |
| last_indexed | 2024-12-10T18:24:13Z |
| publishDate | 2011-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Experimental & Clinical Cancer Research |
| spelling | doaj.art-de4ae93cd7644865a4360165868702c52022-12-22T01:38:08ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662011-11-0130110710.1186/1756-9966-30-107Adiponectin receptor-1 expression is associated with good prognosis in gastric cancerTsukada TomoyaFushida SachioHarada ShinichiTerai ShirohYagi YasumichiKinoshita JunOyama KatsunobuTajima HidehiroFujita HidetoNinomiya ItasuFujimura TakashiOhta Tetsuo<p>Abstract</p> <p>Background</p> <p>Adiponectin is inversely related to BMI, positively correlates with insulin sensitivity, and has anti-atherogenic effects. In recent years, adiponectin has been well studied in the field of oncology. Adiponectin has been shown to have antiproliferative effects on gastric cancer, and adiponectin expression is inversely correlated with clinical staging of the disease. However, no studies have reported the correlation between serum adiponectin and receptor expression with disease progression.</p> <p>Methods</p> <p>In this study, we evaluated expression levels of 2 adiponectin receptors--AdipoR1 and AdipoR2--and attempted to correlate their expression with prognosis in gastric cancer patients. AdipoR1 and AdipoR2 expression in gastric cancer cell lines (MKN45, TMK-1, NUGC3, and NUGC4) was evaluated by western blotting analysis, and the antiproliferative potential of adiponectin was examined in vitro. Serum adiponectin levels were evaluated in 100 gastric cancer patients, and the expression of AdipoR1 and AdipoR2 was assessed by immunohistochemical staining.</p> <p>Results</p> <p>MKN45 and NUGC3 expressed higher levels of AdipoR1 compared to NUGC4, even though there was no significance in AdipoR2 expression. The antiproliferative effect of adiponectin was confirmed in MKN45 and NUGC3 at 10 μg/ml. No significant associations were observed between serum adiponectin levels and clinicopathological characteristics, but lymphatic metastasis and peritoneal dissemination were significantly higher in the negative AdipoR1 immunostaining group (24/32, <it>p </it>= 0.013 and 9/32, <it>p </it>= 0.042, respectively) compared to the positive AdipoR1 group (lymphatic metastasis, 33/68; peritoneal dissemination, 8/68). On the other hand, AdipoR2 expression was only associated with histopathological type (<it>p </it>= 0.001). In survival analysis, the AdipoR1 positive staining group had significantly longer survival rates than the negative staining group (<it>p </it>= 0.01). However, multivariate analysis indicated that AdipoR1 was not an independent prognostic factor on patient's survival on gastric cancer.</p> <p>Conclusions</p> <p>In gastric cancer, adiponectin has the possibility to be involved in cell growth suppression via AdipoR1. The presence of AdipoR1 could be a novel anticancer therapeutic target in gastric cancer.</p>http://www.jeccr.com/content/30/1/107AdiponectinAdipoR1AdipoR2gastric cancersurvival |
| spellingShingle | Tsukada Tomoya Fushida Sachio Harada Shinichi Terai Shiroh Yagi Yasumichi Kinoshita Jun Oyama Katsunobu Tajima Hidehiro Fujita Hideto Ninomiya Itasu Fujimura Takashi Ohta Tetsuo Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer Journal of Experimental & Clinical Cancer Research Adiponectin AdipoR1 AdipoR2 gastric cancer survival |
| title | Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer |
| title_full | Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer |
| title_fullStr | Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer |
| title_full_unstemmed | Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer |
| title_short | Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer |
| title_sort | adiponectin receptor 1 expression is associated with good prognosis in gastric cancer |
| topic | Adiponectin AdipoR1 AdipoR2 gastric cancer survival |
| url | http://www.jeccr.com/content/30/1/107 |
| work_keys_str_mv | AT tsukadatomoya adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT fushidasachio adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT haradashinichi adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT teraishiroh adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT yagiyasumichi adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT kinoshitajun adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT oyamakatsunobu adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT tajimahidehiro adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT fujitahideto adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT ninomiyaitasu adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT fujimuratakashi adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer AT ohtatetsuo adiponectinreceptor1expressionisassociatedwithgoodprognosisingastriccancer |